Research & Development

ReAlta Focuses on Three Major Therapeutic Areas

ReAlta’s efforts are focused on developing therapies that leverage our unique dual targeting mechanisms in three therapeutic areas: Neurology, Pulmonary, and Hematology.

Hypoxic Ischemic Encephalopathy

Hypoxic-ischemic encephalopathy (HIE) is a type of newborn brain damage caused by oxygen deprivation and limited blood flow.

Learn More
Acute Exacerbations of COPD

Acute Exacerbations of COPD (AE COPD) affect individuals suffering from COPD, leading to worsening lung function and hospitalization. This inflammatory disease is primarily driven by neutrophils recruited into the lungs.

Learn More
Graft-versus-Host Disease

Graft-versus-Host Disease (GvHD) is a common disease following bone marrow transplantation where the transplanted white blood cells begin to attack the host body including skin, liver and intestines.

Learn More
Platelet Refractoriness

Platelet Refractoriness is common in cancer patients who receive frequent platelet transfusions and increases the risk of life-threatening hemorrhage.

Learn More
Clinical Pipeline

Our Three Major Therapeutic Areas

Screen Shot 2023 10 17 At 1.35.33 Pm